Severe_JJ
5-fluorouracil_NN
toxicity_NN
secondary_JJ
to_TO
dihydropyrimidine_NN
dehydrogenase_NN
deficiency_NN
._.

A_DT
potentially_RB
more_RBR
common_JJ
pharmacogenetic_JJ
syndrome_NN
._.

This_DT
study_NN
describes_VBZ
the_DT
inheritance_NN
of_IN
a_DT
defect_NN
in_IN
pyrimidine_NN
catabolism_NN
and_CC
its_PRP$
association_NN
with_IN
drug-induced_JJ
toxicity_NN
in_IN
a_DT
patient_NN
receiving_VBG
5-fluorouracil_NN
-LRB-_-LRB-
FUra_NN
-RRB-_-RRB-
as_IN
adjuvant_JJ
chemotherapy_NN
for_IN
breast_NN
carcinoma_NN
._.

The_DT
study_NN
population_NN
included_VBD
the_DT
affected_JJ
patient_NN
-LRB-_-LRB-
proband_NN
-RRB-_-RRB-
,_,
nine_CD
of_IN
her_PRP$
blood_NN
relatives_NNS
,_,
and_CC
seven_CD
healthy_JJ
volunteers_NNS
._.

The_DT
activity_NN
of_IN
dihydropyrimidine_NN
dehydrogenase_NN
-LRB-_-LRB-
DPD_NN
-RRB-_-RRB-
,_,
the_DT
initial_JJ
enzyme_NN
of_IN
pyrimidine_NN
-LRB-_-LRB-
and_CC
FUra_NN
-RRB-_-RRB-
catabolism_NN
,_,
in_IN
peripheral_JJ
blood_NN
mononuclear_JJ
cells_NNS
was_VBD
measured_VBN
in_IN
each_DT
subject_NN
by_IN
a_DT
specific_JJ
radiometric_JJ
assay_NN
using_VBG
FUra_NN
as_IN
the_DT
substrate_NN
._.

The_DT
proband_NN
had_VBD
no_DT
detectable_JJ
DPD_NN
activity_NN
._.

When_WRB
enzyme_NN
levels_NNS
in_IN
the_DT
proband_NN
and_CC
relatives_NNS
were_VBD
compared_VBN
with_IN
that_DT
in_IN
controls_NNS
,_,
an_DT
autosomal_JJ
recessive_JJ
pattern_NN
of_IN
inheritance_NN
was_VBD
demonstrated_VBN
._.

This_DT
is_VBZ
the_DT
third_JJ
patient_NN
with_IN
severe_JJ
FUra_NN
toxicity_NN
secondary_JJ
to_TO
an_DT
alteration_NN
in_IN
pyrimidine_NN
catabolism_NN
and_CC
the_DT
second_JJ
from_IN
our_PRP$
clinic_NN
population_NN
suggesting_VBG
that_IN
the_DT
frequency_NN
of_IN
this_DT
genetic_JJ
defect_NN
may_MD
be_VB
greater_JJR
than_IN
previously_RB
thought_VBN
._.

Monitoring_JJ
DPD_NN
activity_NN
may_MD
be_VB
important_JJ
in_IN
the_DT
management_NN
of_IN
patients_NNS
experiencing_VBG
severe_JJ
toxicity_NN
secondary_JJ
to_TO
FUra_NN
chemotherapy_NN
._.

